Pharma & Healthcare
Global Sclerotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285378
- Pages: 140
- Figures: 142
- Views: 22
In 2024, the global market size of Sclerotherapy was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.
Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sclerotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sclerotherapy.
The Sclerotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sclerotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sclerotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
Segment by Type
Detergents
Osmotic Agents
Chemical Irritants
Segment by Application
Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Sclerotherapy in global and regional level.
Chapter 3: Detailed analysis of Sclerotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sclerotherapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.
Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sclerotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sclerotherapy.
The Sclerotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sclerotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sclerotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
Segment by Type
Detergents
Osmotic Agents
Chemical Irritants
Segment by Application
Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Sclerotherapy in global and regional level.
Chapter 3: Detailed analysis of Sclerotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sclerotherapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Sclerotherapy Product Introduction
1.2 Market by Type
1.2.1 Global Sclerotherapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Detergents
1.2.3 Osmotic Agents
1.2.4 Chemical Irritants
1.3 Market by Application
1.3.1 Global Sclerotherapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Venous Disease
1.3.3 Gastrointestinal Bleeding
1.3.4 Bronchopleural Fistula
1.3.5 Cystic Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sclerotherapy Market Size Estimates and Forecasts
2.2 Sclerotherapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Sclerotherapy Revenue by Region: 2020-2025
2.2.2 Global Sclerotherapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Sclerotherapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sclerotherapy Revenue by Type (2020-2031)
3.1.2 Global Sclerotherapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sclerotherapy Revenue by Application (2020-2031)
3.2.2 Global Sclerotherapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Detergents of Sclerotherapy Revenue Market Share by Application
3.3.2 Osmotic Agents of Sclerotherapy Revenue Market Share by Application
3.3.3 Chemical Irritants of Sclerotherapy Revenue Market Share by Application
4 Global Sclerotherapy by Company
4.1 Global Sclerotherapy Revenue by Company (2020-2025)
4.2 Global Sclerotherapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Sclerotherapy Companies around the World: Ranking by Revenue
4.3.2 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Sclerotherapy Companies Headquarters & Product Type
4.4.1 Global Sclerotherapy Companies Headquarters
4.4.2 Date of International Companies Enter into Sclerotherapy Market
4.4.3 Global Sclerotherapy Companies Product & Service
4.4.4 Detergents Revenue Market Share of Sclerotherapy by Company
4.4.5 Osmotic Agents Revenue Market Share of Sclerotherapy by Company
4.4.6 Chemical Irritants Revenue Market Share of Sclerotherapy by Company
4.5 Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BTG
5.1.1 BTG Corporation Information
5.1.2 BTG Description, Business Overview
5.1.3 BTG Sclerotherapy Products Offered
5.1.4 BTG Sclerotherapy Revenue and Gross Margin (2020-2025)
5.1.5 BTG Sclerotherapy Revenue by Product in 2024
5.1.6 BTG Sclerotherapy Revenue by Application in 2024
5.1.7 BTG Sclerotherapy Revenue by Geographic Area in 2024
5.1.8 BTG Recent Developments
5.2 Kreussler
5.2.1 Kreussler Corporation Information
5.2.2 Kreussler Description, Business Overview
5.2.3 Kreussler Sclerotherapy Products Offered
5.2.4 Kreussler Sclerotherapy Revenue and Gross Margin (2020-2025)
5.2.5 Kreussler Sclerotherapy Revenue by Product in 2024
5.2.6 Kreussler Sclerotherapy Revenue by Application in 2024
5.2.7 Kreussler Sclerotherapy Revenue by Geographic Area in 2024
5.2.8 Kreussler Recent Developments
5.3 LGM Pharma
5.3.1 LGM Pharma Corporation Information
5.3.2 LGM Pharma Description, Business Overview
5.3.3 LGM Pharma Sclerotherapy Products Offered
5.3.4 LGM Pharma Sclerotherapy Revenue and Gross Margin (2020-2025)
5.3.5 LGM Pharma Sclerotherapy Revenue by Product in 2024
5.3.6 LGM Pharma Sclerotherapy Revenue by Application in 2024
5.3.7 LGM Pharma Sclerotherapy Revenue by Geographic Area in 2024
5.3.8 LGM Pharma Recent Developments
5.4 Troikaa
5.4.1 Troikaa Corporation Information
5.4.2 Troikaa Description, Business Overview
5.4.3 Troikaa Sclerotherapy Products Offered
5.4.4 Troikaa Sclerotherapy Revenue and Gross Margin (2020-2025)
5.4.5 Troikaa Sclerotherapy Revenue by Product in 2024
5.4.6 Troikaa Sclerotherapy Revenue by Application in 2024
5.4.7 Troikaa Sclerotherapy Revenue by Geographic Area in 2024
5.4.8 Troikaa Recent Developments
5.5 Changan Tianyu group
5.5.1 Changan Tianyu group Corporation Information
5.5.2 Changan Tianyu group Description, Business Overview
5.5.3 Changan Tianyu group Sclerotherapy Products Offered
5.5.4 Changan Tianyu group Sclerotherapy Revenue and Gross Margin (2020-2025)
5.5.5 Changan Tianyu group Sclerotherapy Revenue by Product in 2024
5.5.6 Changan Tianyu group Sclerotherapy Revenue by Application in 2024
5.5.7 Changan Tianyu group Sclerotherapy Revenue by Geographic Area in 2024
5.5.8 Changan Tianyu group Recent Developments
5.6 Bioniche Pharma Group Ltd
5.6.1 Bioniche Pharma Group Ltd Corporation Information
5.6.2 Bioniche Pharma Group Ltd Description, Business Overview
5.6.3 Bioniche Pharma Group Ltd Sclerotherapy Products Offered
5.6.4 Bioniche Pharma Group Ltd Sclerotherapy Revenue and Gross Margin (2020-2025)
5.6.5 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Product in 2024
5.6.6 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Application in 2024
5.6.7 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Geographic Area in 2024
5.6.8 Bioniche Pharma Group Ltd Recent Developments
5.7 Omega Pharmaceuticals
5.7.1 Omega Pharmaceuticals Corporation Information
5.7.2 Omega Pharmaceuticals Description, Business Overview
5.7.3 Omega Pharmaceuticals Sclerotherapy Products Offered
5.7.4 Omega Pharmaceuticals Sclerotherapy Revenue and Gross Margin (2020-2025)
5.7.5 Omega Pharmaceuticals Sclerotherapy Revenue by Product in 2024
5.7.6 Omega Pharmaceuticals Sclerotherapy Revenue by Application in 2024
5.7.7 Omega Pharmaceuticals Sclerotherapy Revenue by Geographic Area in 2024
5.7.8 Omega Pharmaceuticals Recent Developments
5.8 Angiodynamics
5.8.1 Angiodynamics Corporation Information
5.8.2 Angiodynamics Description, Business Overview
5.8.3 Angiodynamics Sclerotherapy Products Offered
5.8.4 Angiodynamics Sclerotherapy Revenue and Gross Margin (2020-2025)
5.8.5 Angiodynamics Sclerotherapy Revenue by Product in 2024
5.8.6 Angiodynamics Sclerotherapy Revenue by Application in 2024
5.8.7 Angiodynamics Sclerotherapy Revenue by Geographic Area in 2024
5.8.8 Angiodynamics Recent Developments
5.9 ENDO-FLEX
5.9.1 ENDO-FLEX Corporation Information
5.9.2 ENDO-FLEX Description, Business Overview
5.9.3 ENDO-FLEX Sclerotherapy Products Offered
5.9.4 ENDO-FLEX Sclerotherapy Revenue and Gross Margin (2020-2025)
5.9.5 ENDO-FLEX Sclerotherapy Revenue by Product in 2024
5.9.6 ENDO-FLEX Sclerotherapy Revenue by Application in 2024
5.9.7 ENDO-FLEX Sclerotherapy Revenue by Geographic Area in 2024
5.9.8 ENDO-FLEX Recent Developments
5.10 MTW ENDOSKOPIE
5.10.1 MTW ENDOSKOPIE Corporation Information
5.10.2 MTW ENDOSKOPIE Description, Business Overview
5.10.3 MTW ENDOSKOPIE Sclerotherapy Products Offered
5.10.4 MTW ENDOSKOPIE Sclerotherapy Revenue and Gross Margin (2020-2025)
5.10.5 MTW ENDOSKOPIE Sclerotherapy Revenue by Product in 2024
5.10.6 MTW ENDOSKOPIE Sclerotherapy Revenue by Application in 2024
5.10.7 MTW ENDOSKOPIE Sclerotherapy Revenue by Geographic Area in 2024
5.10.8 MTW ENDOSKOPIE Recent Developments
5.11 Cook Medical
5.11.1 Cook Medical Corporation Information
5.11.2 Cook Medical Description, Business Overview
5.11.3 Cook Medical Sclerotherapy Products Offered
5.11.4 Cook Medical Sclerotherapy Revenue and Gross Margin (2020-2025)
5.11.5 Cook Medical Sclerotherapy Revenue by Product in 2024
5.11.6 Cook Medical Sclerotherapy Revenue by Application in 2024
5.11.7 Cook Medical Sclerotherapy Revenue by Geographic Area in 2024
5.11.8 Cook Medical Recent Developments
6 North America
6.1 North America Sclerotherapy Market Size YoY Growth 2020-2031
6.2 North America Sclerotherapy Market Facts & Figures by Country (2020-2031)
6.3 North America Sclerotherapy Revenue by Type (2020-2025)
6.4 North America Sclerotherapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sclerotherapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sclerotherapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Sclerotherapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Sclerotherapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Sclerotherapy Market Size YoY Growth 2020-2031
8.2 Europe Sclerotherapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Sclerotherapy Revenue by Type (2020-2025)
8.4 Europe Sclerotherapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Sclerotherapy Market Size YoY Growth 2020-2031
9.2 Latin America Sclerotherapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Sclerotherapy Revenue by Type (2020-2025)
9.4 Latin America Sclerotherapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sclerotherapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sclerotherapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Sclerotherapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Sclerotherapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sclerotherapy Supply Chain Analysis
11.2 Sclerotherapy Key Raw Materials and Upstream Suppliers
11.3 Sclerotherapy Clients Analysis
11.4 Sclerotherapy Sales Channel and Sales Model Analysis
11.4.1 Sclerotherapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sclerotherapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sclerotherapy Distributors
12 Sclerotherapy Market Dynamics
12.1 Sclerotherapy Industry Trends
12.2 Sclerotherapy Market Drivers
12.3 Sclerotherapy Market Challenges
12.4 Sclerotherapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Sclerotherapy Product Introduction
1.2 Market by Type
1.2.1 Global Sclerotherapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Detergents
1.2.3 Osmotic Agents
1.2.4 Chemical Irritants
1.3 Market by Application
1.3.1 Global Sclerotherapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Venous Disease
1.3.3 Gastrointestinal Bleeding
1.3.4 Bronchopleural Fistula
1.3.5 Cystic Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sclerotherapy Market Size Estimates and Forecasts
2.2 Sclerotherapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Sclerotherapy Revenue by Region: 2020-2025
2.2.2 Global Sclerotherapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Sclerotherapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sclerotherapy Revenue by Type (2020-2031)
3.1.2 Global Sclerotherapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sclerotherapy Revenue by Application (2020-2031)
3.2.2 Global Sclerotherapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Detergents of Sclerotherapy Revenue Market Share by Application
3.3.2 Osmotic Agents of Sclerotherapy Revenue Market Share by Application
3.3.3 Chemical Irritants of Sclerotherapy Revenue Market Share by Application
4 Global Sclerotherapy by Company
4.1 Global Sclerotherapy Revenue by Company (2020-2025)
4.2 Global Sclerotherapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Sclerotherapy Companies around the World: Ranking by Revenue
4.3.2 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Sclerotherapy Companies Headquarters & Product Type
4.4.1 Global Sclerotherapy Companies Headquarters
4.4.2 Date of International Companies Enter into Sclerotherapy Market
4.4.3 Global Sclerotherapy Companies Product & Service
4.4.4 Detergents Revenue Market Share of Sclerotherapy by Company
4.4.5 Osmotic Agents Revenue Market Share of Sclerotherapy by Company
4.4.6 Chemical Irritants Revenue Market Share of Sclerotherapy by Company
4.5 Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BTG
5.1.1 BTG Corporation Information
5.1.2 BTG Description, Business Overview
5.1.3 BTG Sclerotherapy Products Offered
5.1.4 BTG Sclerotherapy Revenue and Gross Margin (2020-2025)
5.1.5 BTG Sclerotherapy Revenue by Product in 2024
5.1.6 BTG Sclerotherapy Revenue by Application in 2024
5.1.7 BTG Sclerotherapy Revenue by Geographic Area in 2024
5.1.8 BTG Recent Developments
5.2 Kreussler
5.2.1 Kreussler Corporation Information
5.2.2 Kreussler Description, Business Overview
5.2.3 Kreussler Sclerotherapy Products Offered
5.2.4 Kreussler Sclerotherapy Revenue and Gross Margin (2020-2025)
5.2.5 Kreussler Sclerotherapy Revenue by Product in 2024
5.2.6 Kreussler Sclerotherapy Revenue by Application in 2024
5.2.7 Kreussler Sclerotherapy Revenue by Geographic Area in 2024
5.2.8 Kreussler Recent Developments
5.3 LGM Pharma
5.3.1 LGM Pharma Corporation Information
5.3.2 LGM Pharma Description, Business Overview
5.3.3 LGM Pharma Sclerotherapy Products Offered
5.3.4 LGM Pharma Sclerotherapy Revenue and Gross Margin (2020-2025)
5.3.5 LGM Pharma Sclerotherapy Revenue by Product in 2024
5.3.6 LGM Pharma Sclerotherapy Revenue by Application in 2024
5.3.7 LGM Pharma Sclerotherapy Revenue by Geographic Area in 2024
5.3.8 LGM Pharma Recent Developments
5.4 Troikaa
5.4.1 Troikaa Corporation Information
5.4.2 Troikaa Description, Business Overview
5.4.3 Troikaa Sclerotherapy Products Offered
5.4.4 Troikaa Sclerotherapy Revenue and Gross Margin (2020-2025)
5.4.5 Troikaa Sclerotherapy Revenue by Product in 2024
5.4.6 Troikaa Sclerotherapy Revenue by Application in 2024
5.4.7 Troikaa Sclerotherapy Revenue by Geographic Area in 2024
5.4.8 Troikaa Recent Developments
5.5 Changan Tianyu group
5.5.1 Changan Tianyu group Corporation Information
5.5.2 Changan Tianyu group Description, Business Overview
5.5.3 Changan Tianyu group Sclerotherapy Products Offered
5.5.4 Changan Tianyu group Sclerotherapy Revenue and Gross Margin (2020-2025)
5.5.5 Changan Tianyu group Sclerotherapy Revenue by Product in 2024
5.5.6 Changan Tianyu group Sclerotherapy Revenue by Application in 2024
5.5.7 Changan Tianyu group Sclerotherapy Revenue by Geographic Area in 2024
5.5.8 Changan Tianyu group Recent Developments
5.6 Bioniche Pharma Group Ltd
5.6.1 Bioniche Pharma Group Ltd Corporation Information
5.6.2 Bioniche Pharma Group Ltd Description, Business Overview
5.6.3 Bioniche Pharma Group Ltd Sclerotherapy Products Offered
5.6.4 Bioniche Pharma Group Ltd Sclerotherapy Revenue and Gross Margin (2020-2025)
5.6.5 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Product in 2024
5.6.6 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Application in 2024
5.6.7 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Geographic Area in 2024
5.6.8 Bioniche Pharma Group Ltd Recent Developments
5.7 Omega Pharmaceuticals
5.7.1 Omega Pharmaceuticals Corporation Information
5.7.2 Omega Pharmaceuticals Description, Business Overview
5.7.3 Omega Pharmaceuticals Sclerotherapy Products Offered
5.7.4 Omega Pharmaceuticals Sclerotherapy Revenue and Gross Margin (2020-2025)
5.7.5 Omega Pharmaceuticals Sclerotherapy Revenue by Product in 2024
5.7.6 Omega Pharmaceuticals Sclerotherapy Revenue by Application in 2024
5.7.7 Omega Pharmaceuticals Sclerotherapy Revenue by Geographic Area in 2024
5.7.8 Omega Pharmaceuticals Recent Developments
5.8 Angiodynamics
5.8.1 Angiodynamics Corporation Information
5.8.2 Angiodynamics Description, Business Overview
5.8.3 Angiodynamics Sclerotherapy Products Offered
5.8.4 Angiodynamics Sclerotherapy Revenue and Gross Margin (2020-2025)
5.8.5 Angiodynamics Sclerotherapy Revenue by Product in 2024
5.8.6 Angiodynamics Sclerotherapy Revenue by Application in 2024
5.8.7 Angiodynamics Sclerotherapy Revenue by Geographic Area in 2024
5.8.8 Angiodynamics Recent Developments
5.9 ENDO-FLEX
5.9.1 ENDO-FLEX Corporation Information
5.9.2 ENDO-FLEX Description, Business Overview
5.9.3 ENDO-FLEX Sclerotherapy Products Offered
5.9.4 ENDO-FLEX Sclerotherapy Revenue and Gross Margin (2020-2025)
5.9.5 ENDO-FLEX Sclerotherapy Revenue by Product in 2024
5.9.6 ENDO-FLEX Sclerotherapy Revenue by Application in 2024
5.9.7 ENDO-FLEX Sclerotherapy Revenue by Geographic Area in 2024
5.9.8 ENDO-FLEX Recent Developments
5.10 MTW ENDOSKOPIE
5.10.1 MTW ENDOSKOPIE Corporation Information
5.10.2 MTW ENDOSKOPIE Description, Business Overview
5.10.3 MTW ENDOSKOPIE Sclerotherapy Products Offered
5.10.4 MTW ENDOSKOPIE Sclerotherapy Revenue and Gross Margin (2020-2025)
5.10.5 MTW ENDOSKOPIE Sclerotherapy Revenue by Product in 2024
5.10.6 MTW ENDOSKOPIE Sclerotherapy Revenue by Application in 2024
5.10.7 MTW ENDOSKOPIE Sclerotherapy Revenue by Geographic Area in 2024
5.10.8 MTW ENDOSKOPIE Recent Developments
5.11 Cook Medical
5.11.1 Cook Medical Corporation Information
5.11.2 Cook Medical Description, Business Overview
5.11.3 Cook Medical Sclerotherapy Products Offered
5.11.4 Cook Medical Sclerotherapy Revenue and Gross Margin (2020-2025)
5.11.5 Cook Medical Sclerotherapy Revenue by Product in 2024
5.11.6 Cook Medical Sclerotherapy Revenue by Application in 2024
5.11.7 Cook Medical Sclerotherapy Revenue by Geographic Area in 2024
5.11.8 Cook Medical Recent Developments
6 North America
6.1 North America Sclerotherapy Market Size YoY Growth 2020-2031
6.2 North America Sclerotherapy Market Facts & Figures by Country (2020-2031)
6.3 North America Sclerotherapy Revenue by Type (2020-2025)
6.4 North America Sclerotherapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sclerotherapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sclerotherapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Sclerotherapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Sclerotherapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Sclerotherapy Market Size YoY Growth 2020-2031
8.2 Europe Sclerotherapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Sclerotherapy Revenue by Type (2020-2025)
8.4 Europe Sclerotherapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Sclerotherapy Market Size YoY Growth 2020-2031
9.2 Latin America Sclerotherapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Sclerotherapy Revenue by Type (2020-2025)
9.4 Latin America Sclerotherapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sclerotherapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sclerotherapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Sclerotherapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Sclerotherapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sclerotherapy Supply Chain Analysis
11.2 Sclerotherapy Key Raw Materials and Upstream Suppliers
11.3 Sclerotherapy Clients Analysis
11.4 Sclerotherapy Sales Channel and Sales Model Analysis
11.4.1 Sclerotherapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sclerotherapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sclerotherapy Distributors
12 Sclerotherapy Market Dynamics
12.1 Sclerotherapy Industry Trends
12.2 Sclerotherapy Market Drivers
12.3 Sclerotherapy Market Challenges
12.4 Sclerotherapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Sclerotherapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Sclerotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Sclerotherapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Sclerotherapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sclerotherapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Sclerotherapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Sclerotherapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Sclerotherapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Sclerotherapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Sclerotherapy Players by Revenue (US$ Million) in 2024
Table 13. Global Sclerotherapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Sclerotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sclerotherapy as of 2024)
Table 15. Global Sclerotherapy Companies Headquarters
Table 16. Date of International Companies Enter into Sclerotherapy Market
Table 17. Global Sclerotherapy Companies Product & Service
Table 18. Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
Table 19. BTG Corporation Information
Table 20. BTG Description and Business Overview
Table 21. BTG Sclerotherapy Product
Table 22. BTG Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. BTG Revenue Proportion of Sclerotherapy by Product in 2024
Table 24. BTG Revenue Proportion of Sclerotherapy by Application in 2024
Table 25. BTG Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 26. BTG Recent Developments
Table 27. Kreussler Corporation Information
Table 28. Kreussler Description and Business Overview
Table 29. Kreussler Sclerotherapy Product
Table 30. Kreussler Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Kreussler Revenue Proportion of Sclerotherapy by Product in 2024
Table 32. Kreussler Revenue Proportion of Sclerotherapy by Application in 2024
Table 33. Kreussler Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 34. Kreussler Recent Developments
Table 35. LGM Pharma Corporation Information
Table 36. LGM Pharma Description and Business Overview
Table 37. LGM Pharma Sclerotherapy Product
Table 38. LGM Pharma Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. LGM Pharma Revenue Proportion of Sclerotherapy by Product in 2024
Table 40. LGM Pharma Revenue Proportion of Sclerotherapy by Application in 2024
Table 41. LGM Pharma Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 42. LGM Pharma Recent Developments
Table 43. Troikaa Corporation Information
Table 44. Troikaa Description and Business Overview
Table 45. Troikaa Sclerotherapy Product
Table 46. Troikaa Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Troikaa Revenue Proportion of Sclerotherapy by Product in 2024
Table 48. Troikaa Revenue Proportion of Sclerotherapy by Application in 2024
Table 49. Troikaa Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 50. Troikaa Recent Developments
Table 51. Changan Tianyu group Corporation Information
Table 52. Changan Tianyu group Description and Business Overview
Table 53. Changan Tianyu group Sclerotherapy Product
Table 54. Changan Tianyu group Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Changan Tianyu group Revenue Proportion of Sclerotherapy by Product in 2024
Table 56. Changan Tianyu group Revenue Proportion of Sclerotherapy by Application in 2024
Table 57. Changan Tianyu group Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 58. Changan Tianyu group Recent Developments
Table 59. Bioniche Pharma Group Ltd Corporation Information
Table 60. Bioniche Pharma Group Ltd Description and Business Overview
Table 61. Bioniche Pharma Group Ltd Sclerotherapy Product
Table 62. Bioniche Pharma Group Ltd Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Bioniche Pharma Group Ltd Revenue Proportion of Sclerotherapy by Product in 2024
Table 64. Bioniche Pharma Group Ltd Revenue Proportion of Sclerotherapy by Application in 2024
Table 65. Bioniche Pharma Group Ltd Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 66. Bioniche Pharma Group Ltd Recent Developments
Table 67. Omega Pharmaceuticals Corporation Information
Table 68. Omega Pharmaceuticals Description and Business Overview
Table 69. Omega Pharmaceuticals Sclerotherapy Product
Table 70. Omega Pharmaceuticals Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Omega Pharmaceuticals Revenue Proportion of Sclerotherapy by Product in 2024
Table 72. Omega Pharmaceuticals Revenue Proportion of Sclerotherapy by Application in 2024
Table 73. Omega Pharmaceuticals Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 74. Omega Pharmaceuticals Recent Developments
Table 75. Angiodynamics Corporation Information
Table 76. Angiodynamics Description and Business Overview
Table 77. Angiodynamics Sclerotherapy Product
Table 78. Angiodynamics Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Angiodynamics Revenue Proportion of Sclerotherapy by Product in 2024
Table 80. Angiodynamics Revenue Proportion of Sclerotherapy by Application in 2024
Table 81. Angiodynamics Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 82. Angiodynamics Recent Developments
Table 83. ENDO-FLEX Corporation Information
Table 84. ENDO-FLEX Description and Business Overview
Table 85. ENDO-FLEX Sclerotherapy Product
Table 86. ENDO-FLEX Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. ENDO-FLEX Revenue Proportion of Sclerotherapy by Product in 2024
Table 88. ENDO-FLEX Revenue Proportion of Sclerotherapy by Application in 2024
Table 89. ENDO-FLEX Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 90. ENDO-FLEX Recent Developments
Table 91. MTW ENDOSKOPIE Corporation Information
Table 92. MTW ENDOSKOPIE Description and Business Overview
Table 93. MTW ENDOSKOPIE Sclerotherapy Product
Table 94. MTW ENDOSKOPIE Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. MTW ENDOSKOPIE Revenue Proportion of Sclerotherapy by Product in 2024
Table 96. MTW ENDOSKOPIE Revenue Proportion of Sclerotherapy by Application in 2024
Table 97. MTW ENDOSKOPIE Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 98. MTW ENDOSKOPIE Recent Developments
Table 99. Cook Medical Corporation Information
Table 100. Cook Medical Description and Business Overview
Table 101. Cook Medical Sclerotherapy Product
Table 102. Cook Medical Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Cook Medical Revenue Proportion of Sclerotherapy by Product in 2024
Table 104. Cook Medical Revenue Proportion of Sclerotherapy by Application in 2024
Table 105. Cook Medical Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 106. Cook Medical Recent Developments
Table 107. North America Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Sclerotherapy Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Sclerotherapy Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 127. Sclerotherapy Key Raw Materials, Industry Status and Trend
Table 128. Sclerotherapy Key Raw Materials and Upstream Suppliers
Table 129. Sclerotherapy Clients Status and Trend
Table 130. Sclerotherapy Typical Clients
Table 131. Sclerotherapy Distributors
Table 132. Sclerotherapy Market Trends
Table 133. Sclerotherapy Market Drivers
Table 134. Sclerotherapy Market Challenges
Table 135. Sclerotherapy Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Sclerotherapy Product Picture
Figure 2. Global Sclerotherapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Sclerotherapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Detergents Product Picture
Figure 5. Osmotic Agents Product Picture
Figure 6. Chemical Irritants Product Picture
Figure 7. Global Sclerotherapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Sclerotherapy Revenue Market Share by Application in 2024 & 2031
Figure 9. Venous Disease
Figure 10. Gastrointestinal Bleeding
Figure 11. Bronchopleural Fistula
Figure 12. Cystic Disease
Figure 13. Sclerotherapy Report Years Considered
Figure 14. Global Sclerotherapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sclerotherapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global Sclerotherapy Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Sclerotherapy Revenue Market Share by Region (2020-2031)
Figure 18. Global Sclerotherapy Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Sclerotherapy Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Detergents of Sclerotherapy Revenue Market Share by Application, 2024 VS 2031
Figure 21. Osmotic Agents of Sclerotherapy Revenue Market Share by Application, 2024 VS 2031
Figure 22. Chemical Irritants of Sclerotherapy Revenue Market Share by Application, 2024 VS 2031
Figure 23. Sclerotherapy Revenue Share by Company (2024)
Figure 24. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Detergents Revenue Proportion by Company in 2024
Figure 26. Osmotic Agents Revenue Proportion by Company in 2024
Figure 27. Chemical Irritants Revenue Proportion by Company in 2024
Figure 28. North America Sclerotherapy Revenue 2020-2031 (US$ Million)
Figure 29. North America Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 30. North America Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Sclerotherapy Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Sclerotherapy Revenue Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 34. Asia-Pacific Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 35. Europe Sclerotherapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Europe Sclerotherapy Revenue Market Share by Country (2020-2031)
Figure 37. Europe Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 38. Europe Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 39. Latin America Sclerotherapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Latin America Sclerotherapy Revenue Market Share by Country (2020-2031)
Figure 41. Latin America Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 42. Latin America Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 43. Middle East and Africa Sclerotherapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Middle East and Africa Sclerotherapy Revenue Market Share by Country (2020-2031)
Figure 45. Middle East and Africa Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 46. Middle East and Africa Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 47. Sclerotherapy Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Sclerotherapy Raw Materials by Region in 2024
Figure 49. Sclerotherapy Distribution Channels
Figure 50. Global Sclerotherapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 51. Global Sclerotherapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global Sclerotherapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Sclerotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Sclerotherapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Sclerotherapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sclerotherapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Sclerotherapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Sclerotherapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Sclerotherapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Sclerotherapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Sclerotherapy Players by Revenue (US$ Million) in 2024
Table 13. Global Sclerotherapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Sclerotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sclerotherapy as of 2024)
Table 15. Global Sclerotherapy Companies Headquarters
Table 16. Date of International Companies Enter into Sclerotherapy Market
Table 17. Global Sclerotherapy Companies Product & Service
Table 18. Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
Table 19. BTG Corporation Information
Table 20. BTG Description and Business Overview
Table 21. BTG Sclerotherapy Product
Table 22. BTG Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. BTG Revenue Proportion of Sclerotherapy by Product in 2024
Table 24. BTG Revenue Proportion of Sclerotherapy by Application in 2024
Table 25. BTG Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 26. BTG Recent Developments
Table 27. Kreussler Corporation Information
Table 28. Kreussler Description and Business Overview
Table 29. Kreussler Sclerotherapy Product
Table 30. Kreussler Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Kreussler Revenue Proportion of Sclerotherapy by Product in 2024
Table 32. Kreussler Revenue Proportion of Sclerotherapy by Application in 2024
Table 33. Kreussler Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 34. Kreussler Recent Developments
Table 35. LGM Pharma Corporation Information
Table 36. LGM Pharma Description and Business Overview
Table 37. LGM Pharma Sclerotherapy Product
Table 38. LGM Pharma Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. LGM Pharma Revenue Proportion of Sclerotherapy by Product in 2024
Table 40. LGM Pharma Revenue Proportion of Sclerotherapy by Application in 2024
Table 41. LGM Pharma Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 42. LGM Pharma Recent Developments
Table 43. Troikaa Corporation Information
Table 44. Troikaa Description and Business Overview
Table 45. Troikaa Sclerotherapy Product
Table 46. Troikaa Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Troikaa Revenue Proportion of Sclerotherapy by Product in 2024
Table 48. Troikaa Revenue Proportion of Sclerotherapy by Application in 2024
Table 49. Troikaa Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 50. Troikaa Recent Developments
Table 51. Changan Tianyu group Corporation Information
Table 52. Changan Tianyu group Description and Business Overview
Table 53. Changan Tianyu group Sclerotherapy Product
Table 54. Changan Tianyu group Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Changan Tianyu group Revenue Proportion of Sclerotherapy by Product in 2024
Table 56. Changan Tianyu group Revenue Proportion of Sclerotherapy by Application in 2024
Table 57. Changan Tianyu group Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 58. Changan Tianyu group Recent Developments
Table 59. Bioniche Pharma Group Ltd Corporation Information
Table 60. Bioniche Pharma Group Ltd Description and Business Overview
Table 61. Bioniche Pharma Group Ltd Sclerotherapy Product
Table 62. Bioniche Pharma Group Ltd Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Bioniche Pharma Group Ltd Revenue Proportion of Sclerotherapy by Product in 2024
Table 64. Bioniche Pharma Group Ltd Revenue Proportion of Sclerotherapy by Application in 2024
Table 65. Bioniche Pharma Group Ltd Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 66. Bioniche Pharma Group Ltd Recent Developments
Table 67. Omega Pharmaceuticals Corporation Information
Table 68. Omega Pharmaceuticals Description and Business Overview
Table 69. Omega Pharmaceuticals Sclerotherapy Product
Table 70. Omega Pharmaceuticals Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Omega Pharmaceuticals Revenue Proportion of Sclerotherapy by Product in 2024
Table 72. Omega Pharmaceuticals Revenue Proportion of Sclerotherapy by Application in 2024
Table 73. Omega Pharmaceuticals Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 74. Omega Pharmaceuticals Recent Developments
Table 75. Angiodynamics Corporation Information
Table 76. Angiodynamics Description and Business Overview
Table 77. Angiodynamics Sclerotherapy Product
Table 78. Angiodynamics Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Angiodynamics Revenue Proportion of Sclerotherapy by Product in 2024
Table 80. Angiodynamics Revenue Proportion of Sclerotherapy by Application in 2024
Table 81. Angiodynamics Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 82. Angiodynamics Recent Developments
Table 83. ENDO-FLEX Corporation Information
Table 84. ENDO-FLEX Description and Business Overview
Table 85. ENDO-FLEX Sclerotherapy Product
Table 86. ENDO-FLEX Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. ENDO-FLEX Revenue Proportion of Sclerotherapy by Product in 2024
Table 88. ENDO-FLEX Revenue Proportion of Sclerotherapy by Application in 2024
Table 89. ENDO-FLEX Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 90. ENDO-FLEX Recent Developments
Table 91. MTW ENDOSKOPIE Corporation Information
Table 92. MTW ENDOSKOPIE Description and Business Overview
Table 93. MTW ENDOSKOPIE Sclerotherapy Product
Table 94. MTW ENDOSKOPIE Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. MTW ENDOSKOPIE Revenue Proportion of Sclerotherapy by Product in 2024
Table 96. MTW ENDOSKOPIE Revenue Proportion of Sclerotherapy by Application in 2024
Table 97. MTW ENDOSKOPIE Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 98. MTW ENDOSKOPIE Recent Developments
Table 99. Cook Medical Corporation Information
Table 100. Cook Medical Description and Business Overview
Table 101. Cook Medical Sclerotherapy Product
Table 102. Cook Medical Sclerotherapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Cook Medical Revenue Proportion of Sclerotherapy by Product in 2024
Table 104. Cook Medical Revenue Proportion of Sclerotherapy by Application in 2024
Table 105. Cook Medical Revenue Proportion of Sclerotherapy by Geographic Area in 2024
Table 106. Cook Medical Recent Developments
Table 107. North America Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Sclerotherapy Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Sclerotherapy Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Sclerotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Sclerotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Sclerotherapy Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Sclerotherapy Revenue by Application (2020-2025) & (US$ Million)
Table 127. Sclerotherapy Key Raw Materials, Industry Status and Trend
Table 128. Sclerotherapy Key Raw Materials and Upstream Suppliers
Table 129. Sclerotherapy Clients Status and Trend
Table 130. Sclerotherapy Typical Clients
Table 131. Sclerotherapy Distributors
Table 132. Sclerotherapy Market Trends
Table 133. Sclerotherapy Market Drivers
Table 134. Sclerotherapy Market Challenges
Table 135. Sclerotherapy Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Sclerotherapy Product Picture
Figure 2. Global Sclerotherapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Sclerotherapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Detergents Product Picture
Figure 5. Osmotic Agents Product Picture
Figure 6. Chemical Irritants Product Picture
Figure 7. Global Sclerotherapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Sclerotherapy Revenue Market Share by Application in 2024 & 2031
Figure 9. Venous Disease
Figure 10. Gastrointestinal Bleeding
Figure 11. Bronchopleural Fistula
Figure 12. Cystic Disease
Figure 13. Sclerotherapy Report Years Considered
Figure 14. Global Sclerotherapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sclerotherapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global Sclerotherapy Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Sclerotherapy Revenue Market Share by Region (2020-2031)
Figure 18. Global Sclerotherapy Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Sclerotherapy Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Detergents of Sclerotherapy Revenue Market Share by Application, 2024 VS 2031
Figure 21. Osmotic Agents of Sclerotherapy Revenue Market Share by Application, 2024 VS 2031
Figure 22. Chemical Irritants of Sclerotherapy Revenue Market Share by Application, 2024 VS 2031
Figure 23. Sclerotherapy Revenue Share by Company (2024)
Figure 24. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Detergents Revenue Proportion by Company in 2024
Figure 26. Osmotic Agents Revenue Proportion by Company in 2024
Figure 27. Chemical Irritants Revenue Proportion by Company in 2024
Figure 28. North America Sclerotherapy Revenue 2020-2031 (US$ Million)
Figure 29. North America Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 30. North America Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Sclerotherapy Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Sclerotherapy Revenue Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 34. Asia-Pacific Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 35. Europe Sclerotherapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Europe Sclerotherapy Revenue Market Share by Country (2020-2031)
Figure 37. Europe Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 38. Europe Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 39. Latin America Sclerotherapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Latin America Sclerotherapy Revenue Market Share by Country (2020-2031)
Figure 41. Latin America Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 42. Latin America Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 43. Middle East and Africa Sclerotherapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Middle East and Africa Sclerotherapy Revenue Market Share by Country (2020-2031)
Figure 45. Middle East and Africa Sclerotherapy Revenue Market Share by Type (2020-2025)
Figure 46. Middle East and Africa Sclerotherapy Revenue Market Share by Application (2020-2025)
Figure 47. Sclerotherapy Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Sclerotherapy Raw Materials by Region in 2024
Figure 49. Sclerotherapy Distribution Channels
Figure 50. Global Sclerotherapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 51. Global Sclerotherapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232